# P. Joly

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/p-joly/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,274 |
| Field | Autoimmune Bullous Skin Diseases |
| h-index | 76 |
| i10-index | 253 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5050985511 |
| ORCID iD | https://orcid.org/0000-0002-5734-0255 |
| Works | 650 |

## Researcher papers

- [Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus](https://scholariq.org/papers/consensus-statement-on-definitions-of-disease-end-points-and-therapeutic/)
- [Diagnosis and management of pemphigus: Recommendations of an international panel of experts](https://scholariq.org/papers/diagnosis-and-management-of-pemphigus-recommendations-of-an-international-panel/)
- [Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts](https://scholariq.org/papers/definitions-and-outcome-measures-for-bullous-pemphigoid-recommendations-by-an/)
- [Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)](https://scholariq.org/papers/updated-s2k-guidelines-on-the-management-of-pemphigus-vulgaris-and-foliaceus/)
- [Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)](https://scholariq.org/papers/updated-scp-s2-scp-k-guidelines-for-the-management-of-bullous-pemphigoid/)
- [Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial](https://scholariq.org/papers/adjuvant-vemurafenib-in-resected-brafv600-mutation-positive-melanoma-brim8-a/)

## Researcher topics

- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions-2/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.